We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$247M
Cap. Flow
-$496M
Cap. Flow %
-48.88%
Top 10 Hldgs %
63.97%
Holding
140
New
46
Increased
31
Reduced
3
Closed
42
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.3 years

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$5.48M
3
OTIC
Otonomy, Inc.
OTIC
+$3.27M
4
INSM icon
Insmed
INSM
+$2.74M
5
FNSR
Finisar Corp
FNSR
+$2.04M

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$14.9M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$1.64M
3
RAI
Reynolds American Inc
RAI
+$1.15M
4
AWH icon
Allied World Assurance Co Hld Lt
AWH
+$825K
5
MBLY icon
Mobileye N.V.
MBLY
+$691K

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.88%
2 Healthcare 3.4%
3 Communication Services 0.4%
4 Technology 0.31%
5 Financials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ZGNX
1
PUT
DELISTED
Zogenix, Inc.
ZGNX
$62.7M 6.18%
1,790,200
+1,588,700
+788% +$21.6M
2017 Q2
1 quarter
NXH icon
2
CALL
Neighborhood Intelligence Inc
NXH
$188M
$40.7M 4.01%
+1,822,139
New +$27.5M
2017 Q3
0 quarters
NXPI icon
3
CALL
NXP Semiconductors
NXPI
$58.3B
$39M 3.85%
345,300
+292,300
+552% +$32.6M
2017 Q1
2 quarters
PTCT icon
4
PUT
PTC Therapeutics
PTCT
$5.09B
$34.7M 3.42%
+1,735,300
New +$34M
2017 Q3
0 quarters
BMY icon
5
CALL
Bristol-Myers Squibb
BMY
$124B
$25.5M 2.51%
+400,000
New +$23.4M
2017 Q3
0 quarters
NXH icon
6
PUT
Neighborhood Intelligence Inc
NXH
$188M
$20.6M 2.03%
+920,653
New +$13.9M
2017 Q3
0 quarters
NXPI icon
7
PUT
NXP Semiconductors
NXPI
$58.3B
$18.7M 1.84%
165,600
+45,000
+37% +$5.02M
2017 Q2
1 quarter
INTC icon
8
PUT
Intel
INTC
$504B
$15.2M 1.5%
400,000
+200,000
+100% +$7.11M
2017 Q2
1 quarter
PTCT icon
9
PTC Therapeutics
PTCT
$5.09B
$12.3M 1.21%
+612,543
New +$12M
2017 Q3
0 quarters
INSM icon
10
PUT
Insmed
INSM
$21.7B
$11.8M 1.16%
376,700
+81,700
+28% +$1.56M
2017 Q1
2 quarters
SIOX
11
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$10.1M 1%
184,400
+83,450
+83% +$14.1M
2017 Q1
2 quarters
IMMU
12
CALL
DELISTED
Immunomedics Inc
IMMU
$10.1M 0.99%
720,300
+259,100
+56% +$2.58M
2017 Q1
2 quarters
ANIP icon
13
PUT
ANI Pharmaceuticals
ANIP
$1.66B
$9.58M 0.94%
182,500
+52,500
+40% +$2.5M
2016 Q4
3 quarters
IMMU
14
PUT
DELISTED
Immunomedics Inc
IMMU
$8.69M 0.86%
621,800
+174,600
+39% +$1.74M
2017 Q2
1 quarter
INSM icon
15
Insmed
INSM
$21.7B
$7.51M 0.74%
240,600
+143,870
+149% +$2.74M
2017 Q2
1 quarter
INSM icon
16
CALL
Insmed
INSM
$21.7B
$6.64M 0.65%
+213,000
New +$4.06M
2017 Q3
0 quarters
NBIX icon
17
Neurocrine Biosciences
NBIX
$13.9B
$6.36M 0.63%
+103,800
New +$5.48M
2017 Q3
0 quarters
LCI
18
PUT
DELISTED
Lannett Company, Inc.
LCI
$6.27M 0.62%
+84,825
New +$6.23M
2017 Q3
0 quarters
IVC
19
PUT
DELISTED
Invacare Corporation
IVC
$5.24M 0.52%
333,300
+233,300
+233% +$3.33M
2017 Q2
1 quarter
DYNC icon
20
DELISTED
Vistra Energy Corp.
DYNC
$5.07M 0.5%
75,000
– –
2017 Q2
1 quarter
ZGNX
21
CALL
DELISTED
Zogenix, Inc.
ZGNX
$4.7M 0.46%
134,000
+108,200
+419% +$1.47M
2016 Q4
3 quarters
VGR icon
22
PUT
DELISTED
Vector Group Ltd.
VGR
$4.1M 0.4%
310,905
+82,390
+36% +$1.07M
2016 Q4
3 quarters
DERM icon
23
PUT
DELISTED
Dermira, Inc.
DERM
$3.24M 0.32%
+120,100
New +$3.14M
2017 Q3
0 quarters
KYNB icon
24
CALL
Kyntra Bio
KYNB
$21.7M
$3.06M 0.3%
+2,280
New +$2.4M
2017 Q3
0 quarters
TEVA icon
25
PUT
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
$2.5M 0.25%
+142,300
New +$3.2M
2017 Q3
0 quarters
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, DLD Asset Management held 140 positions worth $1.02B, up 32% from $768M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

DLD Asset Management withdrew a net $496M in Q3 2017, closing 42 positions and reducing 3 holdings. Its most notable exit was Arista Networks, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 96% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, DLD Asset Management opened a new position in PTC Therapeutics worth $12.3M.

  • DLD Asset Management's largest Q3 2017 buy was PTC Therapeutics: 612,543 shares worth $12.3M.
  • DLD Asset Management added most to Insmed in Q3 2017, an estimated $2.74M increase.
  • DLD Asset Management's biggest Q3 2017 reduction was Brocade Communications Systems, Inc. NEW, cutting an estimated $138K.
  • DLD Asset Management fully exited Arista Networks in Q3 2017, selling an estimated $14.9M.
  • DLD Asset Management's ten largest holdings make up 64% of its $1.02B portfolio in Q3 2017.
  • DLD Asset Management opened 46 new positions and closed 42 in Q3 2017.
  • DLD Asset Management's portfolio value rose 32% quarter-over-quarter to $1.02B.

Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.